Search CommunityWalk:


Biosynexus Incorporated

9298 Gaither Road
Gaithersburg, MD 20877, USA

Category: Biotechnology/Biopharmaceutical

Used in the following map:

Maryland Biotech Industry Map

Biosynexus Incorporated is a biopharmaceutical company focused on the development of monoclonal antibody. The company's mission is to bring products to the market for the prevention and treatment of bacterial infections with emphasis on the prevention of staphylococcal infections in VLBW infants. It is a wholly owned subsidiary of QVT Fund LP.

Biosynexus' product portfolio includes: Pagibaximab, a monoclonal antibody indicated for the treatment of staphylococcal bloodstream infections in very low-birth weight infants; Lysostaphin, a recombinant bacterial derived enzyme indicated for the treatment of life threatening staphylococcal infections; and Nisin, a topical antibiotic indicated for the treatment of staphylococcal skin infections.

Biosynexus has collaborations with GlaxoSmithKline plc, Avecia Biologics Limited, Nutrition 21 Inc, Fujifilm Diosynth Biotechnologies (formerly MSD Biologics (UK) Ltd) etc.